Pacific Edge upbeat about latest move for new Cxbladder test

Pacific Edge upbeat about latest move for new Cxbladder test
Pacific Edge says Cxbladder Triage Plus delivers “significant performance improvements” compared to its existing tests. Image: Pacific Edge)
Rebecca Howard
Pacific Edge is upbeat about the draft gapfill or reimbursement rates for its new Cxbladder Triage Plus test from the US Centres for Medicare and Medicaid Services.Gapfill prices are proposed reimbursement rates for new or unpriced clinical diagnostic laboratory tests.The median price for Cxbladder Triage Plus is US$1,018 (NZ$1,708), according to the gapfill prices.When finalised, the US Centres for Medicare and Medicaid Services (CMS) price for Triage Plus sets the amount Pacific Edge will be reimbursed for all patients with Medicare and Medic...

More Markets

NZ sharemarket drops after weak GDP data
Markets Market Close

NZ sharemarket drops after weak GDP data

Stats NZ data showed NZ's gross domestic product fell 0.9% in the June quarter.

Seeking a faster, sharper ComCom
Economy

Seeking a faster, sharper ComCom

A ‘gold standard’ approach and siloed structure slow the ComCom down.

NZ dollar on watch ahead of 3Q GDP, Fed signals
Markets

NZ dollar on watch ahead of 3Q GDP, Fed signals

Economists expect NZ GDP to shrink 0.3% in the June quarter after March growth.

Craigs beefs up in Hawkes Bay, eyes further expansion
Finance

Craigs beefs up in Hawkes Bay, eyes further expansion

Craigs looks to further expansion as it confirms the Somerset Smith Partners deal.